Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,525,693
+$381,261 QoQ
Shares Held
6,063
+15.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#2,160
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLC Capital Advisors holds $21,615,806 across 11 Drug Manufacturers - General names. ABBV ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
86,579 | $11,125,401 | |
| 2 | JNJ |
Johnson & Johnson
|
13,403 | $3,403,959 | |
| 3 | PFE |
Pfizer Inc
|
66,092 | $1,591,495 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
6,063 | $1,525,693 | |
| 5 | LLY |
ELI LILLY & Co
|
1,111 | $1,332,566 | |
| 6 | AMGN |
Amgen Inc
|
2,086 | $755,382 | |
| 7 | NVS |
Novartis AG
|
3,066 | $480,503 | |
| 8 | NVO |
Novo Nordisk A S
|
9,824 | $470,962 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,525,693 | 6,063 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,144,432 | 5,262 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,228,590 | 5,377 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,300,791 | 5,618 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,041,885 | 5,613 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,087,199 | 5,189 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $871,973 | 4,907 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $942,374 | 4,772 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $980,579 | 5,717 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,230,449 | 6,757 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,068,053 | 6,892 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,036,265 | 6,952 | Shares | Sole | 2024-01-18 | |
| 2023-06-30 | $947,421 | 7,032 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,280,059 | 8,032 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,668,784 | 10,326 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,473,088 | 10,976 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,905,463 | 12,441 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,016,810 | 12,441 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,731,901 | 12,791 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,446,428 | 13,409 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $1,510,389 | 13,409 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,442,464 | 13,329 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,417,487 | 13,229 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,083,488 | 12,370 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $1,072,027 | 10,919 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $716,643 | 9,406 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||